Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Baird

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Dairy Science|July 16, 2010
Short communication: risk of severe heel erosion increased with parity and stage of lactation in freestall-housed dairy cowsN Chapinal, L G Baird, L C Pinheiro Machado, et al.
Clinical Immunology and Immunopathology|May 1, 1984
Association of CSF IgG concentration and immunoglobulin allotype in multiple sclerosis and optic neuritisM Sandberg-Wollheim, L G Baird, M S Schanfield, et al.
Clinical Pharmacology and Therapeutics|August 22, 2013
Legal foundations of adaptive licensingK Oye, L G Baird, A Chia, et al.
Tissue Engineering|December 4, 1998
Voluntary guidance for the development of tissue-engineered productsD R Omstead, L G Baird, L Christenson, et al.
Journal of Dairy Science|November 25, 2010
Effectiveness of different footbath solutions in the treatment of digital dermatitis in dairy cowsM H M Speijers, L G Baird, G A Finney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1984
Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigenA I Lazarovits, R A Moscicki, J T Kurnick, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1985
Studies with monoclonal antibodies against brush border antigens in Heymann nephritisA K Bhan, E E Schneeberger, L G Baird, et al.
Clinical Pharmacology and Therapeutics|July 10, 2014
Accelerated access to innovative medicines for patients in needL G Baird, R Banken, H-G Eichler, et al.
Clinical Pharmacology and Therapeutics|February 17, 2012
Adaptive licensing: taking the next step in the evolution of drug approvalH-G Eichler, K Oye, L G Baird, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patientsH-G Eichler, L G Baird, R Barker, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Dairy Science|July 16, 2010
Short communication: risk of severe heel erosion increased with parity and stage of lactation in freestall-housed dairy cowsN Chapinal, L G Baird, L C Pinheiro Machado, et al.
Clinical Immunology and Immunopathology|May 1, 1984
Association of CSF IgG concentration and immunoglobulin allotype in multiple sclerosis and optic neuritisM Sandberg-Wollheim, L G Baird, M S Schanfield, et al.
Clinical Pharmacology and Therapeutics|August 22, 2013
Legal foundations of adaptive licensingK Oye, L G Baird, A Chia, et al.
Tissue Engineering|December 4, 1998
Voluntary guidance for the development of tissue-engineered productsD R Omstead, L G Baird, L Christenson, et al.
Journal of Dairy Science|November 25, 2010
Effectiveness of different footbath solutions in the treatment of digital dermatitis in dairy cowsM H M Speijers, L G Baird, G A Finney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1984
Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigenA I Lazarovits, R A Moscicki, J T Kurnick, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1985
Studies with monoclonal antibodies against brush border antigens in Heymann nephritisA K Bhan, E E Schneeberger, L G Baird, et al.
Clinical Pharmacology and Therapeutics|July 10, 2014
Accelerated access to innovative medicines for patients in needL G Baird, R Banken, H-G Eichler, et al.
Clinical Pharmacology and Therapeutics|February 17, 2012
Adaptive licensing: taking the next step in the evolution of drug approvalH-G Eichler, K Oye, L G Baird, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patientsH-G Eichler, L G Baird, R Barker, et al.
Pageof 2